SCHEDULE: Susquehanna Affiliates Disclose 5.6% Stake in Core Scientific
Beneficial Ownership Report
A group of affiliated Susquehanna entities has reported a collective beneficial ownership of 5.6% in Core Scientific, Inc., totaling 17,376,097 shares.
Summary
- G1 Execution Services, LLC, SIG Brokerage, LP, Susquehanna Investment Group, and Susquehanna Securities, LLC, all affiliated independent broker-dealers, have filed a Schedule 13G.
- The group collectively beneficially owns 17,376,097 shares of Core Scientific, Inc. common stock.
- This aggregate ownership represents 5.6% of Core Scientific's outstanding common stock.
- The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
- The reported holdings include a mix of common shares, options to buy shares, and warrants to purchase shares.
- Specifically, Susquehanna Securities, LLC holds the largest portion with 16,618,391 shares, including 14,954,900 options and 226,741 warrants.
- SIG Brokerage, LP holds 300,000 shares, consisting entirely of options.
- Susquehanna Investment Group holds 451,901 shares, including 451,500 options.
- G1 Execution Services, LLC holds 5,805 shares, including 2,298 warrants.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this filing as moderately positive. While a Schedule 13G is a factual disclosure, the emergence of a significant institutional holder like Susquehanna can be interpreted as a positive signal of investor interest and confidence in Core Scientific.
Positives
- The disclosure of a significant 5.6% stake by a reputable financial group like Susquehanna may signal institutional confidence in Core Scientific's long-term prospects.
- The acquisition of shares in the ordinary course of business, rather than for control purposes, suggests a strategic investment interest.
Negatives
- NA
Risks
- NA
Future Outlook
NA
Industry Context
StockSavvy.ai notes that Schedule 13G filings are routine disclosures by institutional investors who acquire more than 5% of a company's stock, indicating a passive investment intent. The filing by Susquehanna affiliates suggests a notable institutional presence in Core Scientific, a company operating in the cryptocurrency mining sector. Such disclosures can sometimes be viewed positively by the market as they signal a vote of confidence from sophisticated investors, potentially attracting further interest.
Comparison to Industry Standards
- NA
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake may enhance investor confidence and potentially influence market perception positively.
- Company Management: Awareness of a large institutional holder may influence strategic decisions, though the filing indicates a passive investment.
Key Dates
| Date | Description |
|---|---|
| 2025-10-20 | Date as of which Core Scientific's Quarterly Report on Form 10-Q indicated 310,061,300 shares outstanding. |
| 2025-12-31 | Date of event which requires the filing of this Schedule 13G statement. |
| 2026-02-12 | Date the Schedule 13G and Joint Filing Agreement were signed. |
Recommendation
holdThe filing indicates a significant institutional investment by Susquehanna affiliates, which can be a positive signal for Core Scientific. However, a Schedule 13G filing primarily discloses ownership and does not provide operational or financial performance details. While the institutional interest is noteworthy, it is insufficient on its own to warrant a 'buy' or 'sell' recommendation without further analysis of the company's fundamentals, industry trends, and market conditions. Therefore, a 'hold' recommendation is appropriate, suggesting investors maintain their current position while awaiting more comprehensive financial and operational updates.
Keywords
Core Scientific, CORZ, Schedule 13G, Beneficial Ownership, Susquehanna, Institutional Investment, Common Stock, Options, Warrants, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.